A strategic relationship has been formed between Anthem Inc. (NYSE: ANTM) and New Jersey-based Quest Diagnostics (NYSE: DGX) on several outcome-based programs designed to improve the health care experience.
The companies say they will work together to try to improve care delivery efficiency and reduce costs for patients. The partners say they aim to create pricing transparency, enhance consumer engagement and improve operations.
“We are pleased to collaborate with Quest Diagnostics,” said Paul Marchetti, senior vice president of healthcare management for Anthem Inc. “Quest’s tools and programs will provide critical insights to enable better health care for the consumers and communities we serve.”
The work will focus on clients in California, Connecticut, Georgia, Indiana, Kentucky, Maine, Missouri, New Hampshire, New York, Ohio, Virginia and Wisconsin.
“We value our relationship with Anthem, and are excited about the framework of this agreement,” said Jim Davis, Executive Vice President, General Diagnostics of Quest Diagnostics. “We look forward to demonstrating how our innovative solutions can help Anthem drive improvements in health care.”